Sovicell
Latest round
- Series D
Last raised
- Mar 2007
Total raised
- $1.2M
Investors
- 2
About Sovicell
Founded in Leipzig, Germany, Sovicell GmbH specializes in ADME and DMPK solutions.19 mn.Sovicell specializes in the development and provision of ready-to-use ADME (Absorption, Distribution, Metabolism, and Excretion) and DMPK (Drug Metabolism and Pharmacokinetics) test kits and services tailored for drug discovery. Their core offerings include Transil 96-well assay kits designed to assess plasma protein binding and membrane permeability, as well as specialized assays for challenging compounds such as lipophilic and tightly bound drugs. These kits simplify the assay process by requiring only the addition of the test item, with all necessary components provided, thus enabling rapid results within 30 minutes. Sovicell's customers primarily comprise pharmaceutical companies, biotech firms, and research institutions engaged in drug development across North America, Europe, and parts of Asia.Sovicell generates revenue through the sales of its Transil assay kits and associated assay development services, which are structured as direct-to-business transactions. Clients typically purchase these kits based on their specific research needs, with transactions often completed through standard procurement processes. The company offers various specialized assay kits, including those targeting plasma protein binding, which cater to the unique requirements of different drug types. Additionally, Sovicell may engage in contracts for assay development services, providing tailored solutions to clients looking to optimize their drug discovery workflows.Sovicell GmbH plans to expand its product line by developing new assay kits aimed at addressing the specific needs of emerging drug compounds. The company is focused on entering new geographical markets, specifically targeting Asia and North America by 2025.
Who invested in Sovicell
2 investors across 1 round
See all investors in Sovicell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Mar 5, 2007
Amount
$1.2M
Investors
Questions about Sovicell
Who invested in Sovicell?
Sovicell has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sovicell raised?
Sovicell has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sovicell last raise money?
Sovicell's most recent round on record is a Series D, in Mar 2007.
What does Sovicell do?
Founded in Leipzig, Germany, Sovicell GmbH specializes in ADME and DMPK solutions.
Where is Sovicell headquartered?
Sovicell is headquartered in Leipzig, Germany.
Which VCs invest in companies like Sovicell?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Sovicell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Sovicell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.